Literature DB >> 6052955

The effect of uremic plasma on lymphocyte transformation.

M R Silk.   

Abstract

Mesh:

Year:  1967        PMID: 6052955

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


× No keyword cloud information.
  19 in total

1.  In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.

Authors:  D P Sengar; A Rashid; J E Harris
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

2.  Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vitro.

Authors:  S Ikemoto; T Kishimoto; S Wada; N Hayahara; M Maekawa
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Variability of sequential studies of lymphocyte blastogenesis in normal adults.

Authors:  J R Graybill; R H Alford
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

4.  Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors.

Authors:  R N MacSween; M A Thomas
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

5.  Lymphocyte transformation in chronic renal failure.

Authors:  L S Nakhla; M J Goggin
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

6.  Inhibition of lymphocyte transformation by guanidinosuccinic acid, a surplus metabolite in uremia.

Authors:  R G Slavin; C D Fitch
Journal:  Experientia       Date:  1971

7.  Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis.

Authors:  C C Hsu; C M Leevy
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

8.  Host immune status in uraemia. II. Serum factors and lymphocyte transformation.

Authors:  E Stewart; T E Miller
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

9.  Immunosuppressive factors in uraemic sera are composed of both dialysable and non-dialysable components.

Authors:  K Kamata; M Okubo; M Sada
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

10.  Labile inhibitor of lymphocyte transformation in plasma from a patient and subacute sclerosing panencephalitis.

Authors:  J Allen; J Oppenheim; J A Brody; J Miller
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.